Dr. Brooke Morrisseau is the CEO of Cellovian Scientific and a regenerative medicine and biologics educator specializing in the translation of foundational cell physiology, biologic structure, and tissue engineering principles into responsible clinical education and implementation. Her work focuses on helping clinicians develop a signaling- and structure-based understanding of biologic systems to support informed, independent decision-making in clinical practice. She has served as a scientist at SUNY Oswego and Keuka College, where her work involved biologics and protein purification with emphasis on biologic structure and cell signaling mechanisms. Brooke has also served as an educator at the University of South Florida, teaching body composition and human metabolism, further grounding her work in applied physiology and translational science. Her entry into regenerative medicine was shaped by a personal experience that led to deeper study of cell science and the body's inherent repair processes. Today, her teaching emphasizes education-first frameworks, manufacturing transparency, and ethical knowledge transfer, underscoring that sustainable progress in regenerative medicine and biologics depends not only on scientific innovation, but on how well foundational physiology is understood and responsibly implemented in clinical settings.

Dr. Andisheh Dadashi is a computational biologist, statistician, mathematician, and assistant professor at the University of New Mexico–Valencia, USA. With dual Master’s degrees in Statistics and Mathematical Statistics, and a Ph.D. in Computer Science, Dr. Dadashi specializes in high-performance computing, metabolic modeling, and data-driven systems biology. Her interdisciplinary approach bridges computer science, statistics, and molecular biology. Her research presents the first stage-specific in silico model of human peri-implantation embryo metabolism, combining flux balance analysis (FBA) and network expansion algorithms to simulate complex metabolic processes during early development. This model has led to novel insights into the lactate-associated malate-aspartate shuttle (MAS) and metabolic regulation under varying oxygen and nutrient conditions, offering implications for regenerative medicine, stem cell research, and developmental biology. Dr. Dadashi has received international recognition for her contributions to computational biology and embryology, including Best Presentation Awards at ICBCB in Tokyo and invitations to serve as a session chair at global symposia. She is passionate about integrating mathematical modeling with experimental data to drive discoveries in embryonic development and biomedical innovation. In addition to her research, Dr. Dadashi is a dedicated educator and curriculum innovator, having taught a wide range of courses across computer science, data science, statistics, and mathematics. She is deeply committed to inclusive, interdisciplinary pedagogy, and was honored with the 2025 UNM Teaching Excellence Award in recognition of her outstanding contributions to student learning and mentorship.

Dr. Kaijing Yan, Ph.D. is the Director of the Tasly Institute of Life Rejuvenation in Tianjin, China, and Chairman of the Tasly Bio-Medicinal Industry Group. An accomplished scientist and entrepreneur, Dr. Yan holds degrees in computer science, finance, and traditional Chinese medicine, along with postdoctoral training in stem cells and regenerative medicine. He leads pioneering research that integrates AI, single-cell omics, and clinical translation of regenerative therapies, contributing to U.S. FDA–approved stem cell products and advancing the global understanding and clinical application of mesenchymal stromal cells (MSCs).

Dr. Omid Liaghati, MD, CCFP, CAPM is a licensed Canadian family physician specializing in chronic pain management. He combines medication and interventional techniques in his practice, including nerve blocks, chemical nerve ablation, PRP therapy, stem cell therapy, and phototherapy to provide comprehensive care for patients with persistent pain.

Dr. Sven Massenhove is a renowned expert in Molecular Science, Biotechnology, and Nanotechnology Engineering, with a strong focus on advancing BioHacking and Anatomy. As an entrepreneur and founder, he leads pioneering initiatives in Stem-Cell, Mitochondria, and DNA-based rejuvenation, leveraging Nanotechnology to enhance therapeutic efficacy and transform healthcare. He developed a quantum algorithm for protein-protein interactions, streamlining the creation of medicines, peptides, beauty products, and food items. Under his guidance, StemRevive-X merges luxury wellness with cutting-edge BioHacking, setting new standards in anatomical excellence and longevity. With a background in Molecular Biology, Stem Cell research, and Nanotechnology, Dr. Massenhove’s expertise spans Neurotropic Science, Morphology, and Human Biology. He also holds the designation of Class 1 Marine Officer and excels in regulatory compliance, green technology optimization, and sustainable system solutions. Committed to innovation, Dr. Massenhove is dedicated to improving healthcare through custom solutions that prioritize efficiency, safety, and sustainability.

Dr. Karl Georges Attieh — PharmD (Massachusetts College of Pharmacy, Boston); PhD in Khavinson Peptides (Saint Petersburg Institute of Bioregulation & Gerontology). He is the youngest member of the World Organisation of Anti-Aging & Preventive Medicine (WOCPM). Dr. Attieh is based at Dermapro, Beirut, Lebanon, and is an international speaker in the fields of longevity, peptides, and functional pharmacology.

Dr. Maryam Asadi Ph.D. in Molecular Medicine diploma from the American Board of Regenerative Medicine. Shiraz ACECR cell therapy department manager CEO and founder of Unihealthcity platform Shiraz ACECR polyclinic manager awarded the American Society of Regenerative Medicine Extraordinary Young Scientist award in 2024 the American Board of Regenerative Medicine as an affiliate in Iran.

Dr. Rozina Badal Munir is an esteemed physician specializing in education in Diagnostic medical ultrasound and regenerative medicine. She received her MBBS from Khyber Medical College Pakistan andheld many board certifications in diagnostic medical sonography and regenerative medicine. With a longstanding position as an Ultrasound Specialist and Instructor at Kaiser Permanente West Los Angeles Medical Center, she has played a great role in promotion of diagnostic medical ultrasound education globally. As the Global Development Director of the American Board of Regenerative Medicine (ABRM), Dr. Munir has led international efforts to standardize the regenerative medicine education and certification across more than 30 countries and established 20 exam centers globally for ABRM written exams. She has also delivered hands-on workshops and symposia worldwide, with a focus on integrating point-of-care ultrasound in regenerative and emergency medicine. Dr. Munir has presented at major national and international conferences and contributed to medical journals in both regenerative medicine and diagnostic medical ultrasound. Her mission continues to mentor and train healthcare professionals globally.

Dr. Massar Alsamraae is a molecular biologist with extensive experience in cancer metabolism and tumor microenvironment research. He earned his Ph.D. from the Northern Institute for Cancer Research at Newcastle University, UK, where he investigated molecular mechanisms of drug resistance and cell signaling in cancer. Currently, his work focuses on metabolic reprogramming, lactate transport, and senescence in cancer progression and metastasis. His research integrates molecular biology, cell biology, and translational approaches to identify novel therapeutic targets in aggressive cancers.

Mrs. Mina Shajarizadeh is a Ph.D. student in Molecular Medicine group department at Tehran University of Medical Sciences, Tehran, Iran. She obtained her Master’s degree in Medical Parasitology in 2018 and her Bachelor’s degree in Laboratory Sciences from Shahid Beheshti University of Medical Sciences, Tehran. She possesses over eleven years of professional experience in laboratories and research, including Cellular and Molecular biology,Biochemistry and Microbiology departments , and Management of Quality Control (QC) Processes in Clinical laboratories. Her research interests focus on stem cell biology and the expression of key genes in cellular differentiation, with a strong emphasis on regenerative medicine and cell therapy. She has collaborated on numerous scientific projects, such as investigating Ascl1 expression in human bone marrow mesenchymal stem cells and their differentiation into pancreatic beta cells, and examining the effects of exosomes secreted by hepatocytes under hyperglycemic conditions on insulin receptors in pancreatic cancer cell lines.

Dr. Sowmithra is a Postdoctoral associate in Dr. Janghoo Lim lab in the Department of Genetics, Yale University School of Medicine in New Haven, United States. She holds a PhD in Biophysics from National Institute of Mental Health and Neurosciences, Bengaluru and master’s in biotechnology and molecular medicine from India. She studied the ‘Neuroprotective role of Mesenchymal stem cells on neural progenitors against hypoxic ischemic like injury’ under the guidance of Dr. Indrani Datta for her doctoral studies. In Lim lab she investigated the cellular phenotypes in human iPSCs derived neurons and astrocytes of spinocerebellar ataxia type 1.

Dr. Latifa Gaddah is an Immunopathologist and Biotherapies Specialist with advanced expertise in immunogenetics, Biotherapies and high-reliability laboratory systems. With an academic and clinical background, including a Master’s degree in Genetics and specialization in Biotherapies and Doctorate in Medecine. She is international fellow of College of American Pathologists and a regional leader in implementing international standards across advanced diagnostics. She serves as a CAP Inspector Team Leader, AABB International Member and Assessor, and previously ISQua International Fellow, supporting institutions in achieving accreditation’s. Her work spans stem cell processing, cryopreservation, potency assessment, immunogenetics characterization, and cellular therapy quality management. She is Assistant Professor of Immunopathology, Immunogenetics Unit University of Medecine Sussa Tunisia. Dr. Gaddah is also the founder of YLM Training & Consultancy, delivering scientific education and capacity building across the MENA region. Her vision centers on integrating biotherapies, precision immunology, and advanced quality systems to elevate patient safety and deliver transformative clinical outcomes.

Dr. Mohammadali Zolfaghari is a PhD in Molecular Medicine and a Diplomate & Alpha Affiliated member of the American Board of Regenerative Medicine (ABRM). He serves as the Research and Development Manager at the Molecular Immunology Research Center, Tehran University of Medical Sciences, and represents Celltech Pharmed Company as its exclusive sales representative. His expertise lies in regenerative medicine, immunotherapy, and precision medicine, with a focus on translating laboratory discoveries into clinical applications. He is dedicated to developing innovative, patient-centered therapeutic strategies and fostering collaborations that advance healthcare through cutting-edge biomedical research.

Dr. Amrita Natarajan is a biomedical researcher with a multidisciplinary background in dentistry, nanomedical sciences, and bioengineering. She holds a B.D.S. from the Army College of Dental Sciences, an M.Tech in Nanomedical Sciences from AIMS, and a Ph.D. in Bioengineering with a focus on Tissue Engineering and Regenerative Medicine from SCTIMST, India. She has received prestigious fellowships from ICMR and CSIR, and has worked on DST-SERB-funded research. Her expertise lies in the development of advanced biomaterials, 3D bioprinted constructs, and in vitro disease models for regenerative therapies targeting cartilage, bone, and kidney tissues. Her work includes biomimetic scaffolds for cartilage repair, patterned hydrogels for renal tissue modeling, electrospun tubule models, and 3D-printed lattice scaffolds for various tissue regeneration applications. Dr. Natarajan previously served as Project Scientist C at ICMR, where she contributed to national biomedical ethics policy, including India’s 2023 CHIS policy statement. Currently, she is a National Science Foundation–funded Postdoctoral Research Scientist at Alabama State University, focusing on AI-driven renal tissue engineering. She also serves on doctoral advisory committees at multiple institutions. Her long-term vision integrates bioinspired design with advanced fabrication technologies for tissue repair and organ function restoration.

Mr. Francis ("Frank") O'Keeffe is an Associate Lecturer at the University of Notre Dame Australia (Sydney). He is currently a PhD candidate nearing the end of his doctoral studies. His research investigates the ethical status of the human embryo. He is perhaps best known for an article titled, "Twinning and Individuation: An Appraisal of the Current Model and Ethical Implications." This work challenges the commonly held belief that identical twins may be formed by embryo splitting up to the fourteenth day of human embryogenesis. Mr O'Keeffe's research has also rejected the possibility that two separate human embryos could fuse into a single viable entity, which has prompted him to propose alternative models by which human chimeras may be formed. He is a critic of legislation which permits embryo experimentation during the first two weeks of human development. He has obtained a Master of Bioethics (MBioeth) and a Bachelor of Laws (LLB) from LaTrobe University (Melbourne).

Mr. Calvin Jefferson is a Doctor of Health Science (DHSc) candidate at Touro University Worldwide and a published author, fine artist, and healthcare professional with over 15 years of experience. His work explores the intersection of socioeconomic equity and public trust in emerging biomedical technologies. Mr. Jefferson’s recent research focuses on regenerative medicine and ethical disparities in patient access and perception. He is also a Service-Disabled Veteran and founder of CE Jefferson Properties LLC.